Controvérsias sobre o transtorno do déficit de atenção e hiperatividade (Portuguese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Controvérsias sobre o transtorno do déficit de atenção e hiperatividade" in Portuguese language version.

refsWebsite

Global rank Portuguese rank

61nih.gov

4^th place

8^th place

58doi.org

2^nd place

4^th place

12web.archive.org

1^st place

11worldcat.org

5^th place

5fda.gov

447^th place

869^th place

4books.google.com

3^rd place

6^th place

3nice.org.uk

3,258^th place

5,177^th place

3archive.org

6^th place

23^rd place

3webmd.com

1,169^th place

809^th place

3pbs.org

198^th place

285^th place

2nybooks.com

1,785^th place

1,925^th place

1uptodate.com

3,771^st place

8,919^th place

1psychrights.org

low place

1rcpsych.org

low place

5,373^rd place

1psychiatryonline.com

low place

1britannica.com

40^th place

17^th place

1caddra.ca

low place

1cdc.gov

218^th place

177^th place

1unodc.org

2,494^th place

1,806^th place

1zenodo.org

621^st place

1,847^th place

1aappublications.org

3,763^rd place

2,565^th place

1reuters.com

49^th place

88^th place

1ubc.ca

1,997^th place

4,237^th place

1hta.ac.uk

low place

1psychiatryonline.org

4,032^nd place

3,054^th place

1cnn.com

28^th place

50^th place

1umich.edu

459^th place

472^nd place

1handle.net

102^nd place

459^th place

1slate.com

259^th place

306^th place

1latimes.com

22^nd place

60^th place

1pharmalot.com

low place

1archive.today

14^th place

110^th place

1independent.co.uk

36^th place

90^th place

1nytimes.com

7^th place

14^th place

1aacap.org

low place

1ama-assn.org

3,257^th place

4,674^th place

1bbc.co.uk

8^th place

13^th place

1telegraph.co.uk

30^th place

57^th place

1timesonline.co.uk

241^st place

304^th place

1nrk.no

849^th place

3,525^th place

aacap.org

«Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder» (PDF). American Academy of Child & Adolescent Psychiatry. Consultado em 9 de outubro de 2008. Cópia arquivada (PDF) em 17 de dezembro de 2008

aappublications.org

pediatrics.aappublications.org

Vitiello B (outubro de 2001). «Psychopharmacology for young children: clinical needs and research opportunities». Pediatrics. 108 (4): 983–989. PMID 11581454. doi:10.1542/peds.108.4.983

ama-assn.org

jama.ama-assn.org

Goldman LS, Genel M, Bezman RJ, Slanetz PJ (abril de 1998). «Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association». JAMA. 279 (14): 1100–1107. PMID 9546570. doi:10.1001/jama.279.14.1100

archive.org

Chriss JJ (2007). Social control: an introduction. Cambridge, UK: Polity. p. 230. ISBN 978-0-7456-3858-4
Szasz, Thomas Stephen (2001). Pharmacracy: medicine and politics in America. New York: Praeger. p. 212. ISBN 0-275-97196-1
Coles, Gerald (1989). The Learning Mystique: A Critical Look at "Learning Disabilities". [S.l.]: Ballantine Books. ISBN 978-0449903513

archive.today

«FDA Warns Five Drugmakers Over ADHD Ads». Pharmalot. UBM Canon Pharmaceutical Media Group. Cópia arquivada em 8 de setembro de 2012

bbc.co.uk

news.bbc.co.uk

«Peer calls for ADHD care review». BBC News. 14 de novembro de 2007. Consultado em 25 de abril de 2010

books.google.com

Parrillo VN (2008). «Attention Deficit Hyperactivity Disorder». Encyclopedia of Social Problems. Sage. p. 63. ISBN 978-1412941655. Consultado em 7 de abril de 2016
American Psychiatric Association (2013), Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, ISBN 978-0890425572, American Psychiatric Association: Arlington, VA
Michael Fitzgerald; Mark Bellgrove; Michael Gill (2007). Handbook of Attention Deficit Hyperactivity Disorder. [S.l.]: John Wiley & Sons. p. 270. ISBN 978-0-470-03215-2
Glenmullen, J. (2000). Prozac Backlash: Overcoming the Dangers of Prozac, Zoloft, Paxil, and Other Antidepressants with Safe, Effective Alternatives. New York: Simon & Schuster. pp. 192–198. ISBN 978-0-7432-0062-2. OCLC 42968080

britannica.com

«Attention-deficit/hyperactivity disorder: Controversy – mental disorder or state of mind?». Encyclopædia Britannica (em inglês). Cópia arquivada em 15 de maio de 2010

caddra.ca

Canadian ADHD Practice Guidelines (PDF), Canadian ADHD Alliance, consultado em 4 de fevereiro de 2011

cdc.gov

Attention-Deficit/Hyperactivity Disorder (ADHD): Recommendations, Centers for Disease Control and Prevention, 24 de junho de 2015, consultado em 13 de julho de 2015

cnn.com

edition.cnn.com

«Ritalin abuse scoring high on college illegal drug circuit». CNN. 8 de janeiro de 2001. Consultado em 25 de abril de 2010

doi.org

dx.doi.org

Faraone SV, et al. (2021). «The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder». Elsevier BV. Neuroscience & Biobehavioral Reviews. 128: 789–818. ISSN 0149-7634. PMC 8328933. PMID 33549739. doi:10.1016/j.neubiorev.2021.01.022
Elder TE (setembro de 2010). «The importance of relative standards in ADHD diagnoses: evidence based on exact birth dates». Journal of Health Economics. 29 (5): 641–656. PMC 2933294. PMID 20638739. doi:10.1016/j.jhealeco.2010.06.003
Merten EC, Cwik JC, Margraf J, Schneider S (2017). «Overdiagnosis of mental disorders in children and adolescents (in developed countries)». Child and Adolescent Psychiatry and Mental Health. 11. 5 páginas. PMC 5240230. PMID 28105068. doi:10.1186/s13034-016-0140-5
Taylor E (abril de 2017). «Attention deficit hyperactivity disorder: overdiagnosed or diagnoses missed?». Archives of Disease in Childhood. 102 (4): 376–379. PMID 27821518. doi:10.1136/archdischild-2016-310487
Mayes R, Bagwell C, Erkulwater J (2008). «ADHD and the rise in stimulant use among children». Harvard Review of Psychiatry (Review). 16 (3): 151–66. PMID 18569037. doi:10.1080/10673220802167782
Ford T, Goodman R, Meltzer H (outubro de 2003). «The British Child and Adolescent Mental Health Survey 1999: the prevalence of DSM-IV disorders». Journal of the American Academy of Child and Adolescent Psychiatry. 42 (10): 1203–1211. PMID 14560170. doi:10.1097/00004583-200310000-00011
Polanczyk, G.; De Lima, M. S.; Horta, B. L.; Biederman, J.; Rohde, L. A. (2007). «The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis». American Journal of Psychiatry (Meta-analysis). 164 (6): 942–948. PMID 17541055. doi:10.1176/appi.ajp.164.6.942
Cortese S, Castellanos FX (outubro de 2012). «Neuroimaging of attention-deficit/hyperactivity disorder: current neuroscience-informed perspectives for clinicians». Curr Psychiatry Rep (Review). 14 (5): 568–578. PMC 3876939. PMID 22851201. doi:10.1007/s11920-012-0310-y
Shaw, Philip; Lerch, Jason; Greenstein, Deanna; Sharp, Wendy; Clasen, Liv; Evans, Alan; Giedd, Jay; Castellanos, F. Xavier; Rapoport, Judith (2006). «Longitudinal Mapping of Cortical Thickness and Clinical Outcome in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder». Arch Gen Psychiatry. 63 (5): 540–549. PMID 16651511. doi:10.1001/archpsyc.63.5.540
Nikolas, Molly A.; Burt, S. Alexandra (1 de fevereiro de 2010). «Genetic and environmental influences on ADHD symptom dimensions of inattention and hyperactivity: a meta-analysis». Journal of Abnormal Psychology (Meta-analysis). 119 (1): 1–17. ISSN 1939-1846. PMID 20141238. doi:10.1037/a0018010
M. T. Acosta; M. Arcos-Burgos; M. Muenke (2004). «Attention deficit/hyperactivity disorder (ADHD): Complex phenotype, simple genotype?». Genetics in Medicine (Review). 6 (1): 1–15. PMID 14726804. doi:10.1097/01.GIM.0000110413.07490.0B
Parens E, Johnston J (2009). «Facts, values, and Attention-Deficit Hyperactivity Disorder (ADHD): an update on the controversies». Child and Adolescent Psychiatry and Mental Health (Workshops). 3 (1). 1 páginas. PMC 2637252. PMID 19152690. doi:10.1186/1753-2000-3-1
Singh I (dezembro de 2008). «Beyond polemics: science and ethics of ADHD». Nature Reviews Neuroscience (Review). 9 (12): 957–964. PMID 19020513. doi:10.1038/nrn2514
Timimi, Sami; Taylor, Eric (janeiro de 2004). «In Debate: ADHD is best understood as a cultural construct». British Journal of Psychiatry. 184 (1): 8–9. PMID 14702221. doi:10.1192/bjp.184.1.8
Barkley, Russell A. (2004). 20 Coendorsers. «Critique or Misrepresentation? A Reply to Timimi et al.». Springer Science and Business Media LLC. Clinical Child and Family Psychology Review. 7 (1): 65–69. ISSN 1096-4037. doi:10.1023/b:ccfp.0000020193.48817.30
Benning, Tony B. (dezembro de 2016). «No such thing as mental illness? Critical reflections on the major ideas and legacy of Thomas Szasz». BJPsych Bulletin (em inglês). 40 (6): 292–295. ISSN 2056-4694. PMC 5353517. PMID 28377805. doi:10.1192/pb.bp.115.053249
Taylor E.; Chadwick O.; Heptinstall E.; et al. (1996). «Hyperactivity and conduct problems as risk factors for adolescent development». Journal of the American Academy of Child and Adolescent Psychiatry. 35 (9): 1213–1226. PMID 8824065. doi:10.1097/00004583-199609000-00019
Meltzer, H.; Gatward, R.; Goodman, R.; Ford, T. (2003). «Mental health of children and adolescents in Great Britain». Informa UK Limited. International Review of Psychiatry. 15 (1–2): 185–187. ISSN 0954-0261. PMID 12745331. doi:10.1080/0954026021000046155
Mahone, E. M.; Wodka, E. L. (2008). «The neurobiological profile of girls with ADHD». Developmental Disabilities Research Reviews. 14 (4): 276–284. PMC 3534724. PMID 19072756. doi:10.1002/ddrr.41 Verifique o valor de |name-list-format=amp (ajuda)
Sciutto M. J., Eisenberg M. (2007). «Evaluating the Evidence For and Against the Overdiagnosis of ADHD». Journal of Attention Disorders. 11 (2): 106–113. PMID 17709814. doi:10.1177/1087054707300094
Cuffe, SP; Moore, CG; McKeown, RE (2005). «Prevalence and correlates of ADHD symptoms in the National Health Interview Survey». Journal of Attention Disorders. 9 (2): 392–401. PMID 16371662. doi:10.1177/1087054705280413
Morely, CP (2010). «Disparities in ADHD assessment, diagnosis and treatment». International Journal of Psychiatry in Medicine. 40 (4): 383–389. PMID 21391409. doi:10.2190/PM.40.4.b
Harrison, JR; Vannest, KJ; Reynolds, CR (2011). «Behaviors that discriminate ADHD in children and adolescents: Primary symptoms, symptoms of comorbid conditions or indicators of functional impairment?». Journal of Attention Disorders. 15 (2): 147–160. PMID 20354233. doi:10.1177/1087054709356170
Morrow, R; Garland, J; Wright, J; Maclure, M; et al. (17 de abril de 2012). «Influence of relative age on diagnosis and treatment of Attention-Deficit/Hyperactivity Disorder in children». Canadian Medical Association Journal. 184 (7): 755–762. PMC 3328520. PMID 22392937. doi:10.1503/cmaj.111619
Able, SL; Johnston, JA; Adler, LA; Swindle, RW (2007). «Functional and psychosocial impairment in adults with undiagnosed ADHD». Psychological Medicine. 37 (1): 97–107. PMID 16938146. doi:10.1017/s0033291706008713
Kessler, RC; Adler, L; Barley, R; Biederman, J; et al. (2006). «The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication». The American Journal of Psychiatry. 163 (4): 716–723. PMC 2859678. PMID 16585449. doi:10.1176/appi.ajp.163.4.716
Manos, MJ (2010). «Nuances of assessment and treatment of ADHD in adults: A guide for psychologists». Professional Psychology: Research and Practice. 41 (6): 511–517. doi:10.1037/a0021476
Bruchmuller, K; Margraf, J; Schneider, S (2012). «Is ADHD diagnosed in accord with diagnostic criteria? Overdiagnosis and influence of client gender on diagnosis». Journal of Consulting and Clinical Psychology. 80 (1): 128–138. PMID 22201328. doi:10.1037/a0026582
Beiderman, J., Joseph; Stephen Farone; Eric Mick (1999). «Clinical correlates of ADHD in females: Findings from a large group of girls ascertained from pediatric and psychiatric referral sources». Journal of the American Academy of Child and Adolescent Psychiatry. 38 (8): 966–975. PMID 10434488. doi:10.1097/00004583-199908000-00012
Norvilitis JM, Fang P (novembro de 2005). «Perceptions of ADHD in China and the United States: a preliminary study». J Atten Disord. 9 (2): 413–424. PMID 16371664. doi:10.1177/1087054705281123
Reason R; Working Party of the British Psychological Society (1999). «ADHD: a psychological response to an evolving concept. (Report of a Working Party of the British Psychological Society)». Journal of Learning Disabilities. 32 (1): 85–91. PMID 15499890. doi:10.1177/002221949903200108
Ford-Jones, Polly Christine (maio de 2015). «Misdiagnosis of attention deficit hyperactivity disorder: 'Normal behaviour' and relative maturity». Paediatrics & Child Health. 20 (4): 200–202. ISSN 1205-7088. PMC 4443828. PMID 26038639. doi:10.1093/pch/20.4.200
Marwick, C. (11 de janeiro de 2003). «US doctor warns of misuse of prescribed stimulants». Washington, DC. BMJ (news article). 326 (7380): 67. ISSN 0959-8138. PMC 1125021. PMID 12521954. doi:10.1136/bmj.326.7380.67
Jensen PS, Kettle L, Roper MT, et al. (julho de 1999). «Are stimulants overprescribed? Treatment of ADHD in four U.S. communities». Journal of the American Academy of Child and Adolescent Psychiatry. 38 (7): 797–804. PMID 10405496. doi:10.1097/00004583-199907000-00008
Lakhan SE, Hagger-Johnson GE (2007). «The impact of prescribed psychotropics on youth». Clin Pract Epidemiol Ment Health. 3 (1). 21 páginas. PMC 2100041. PMID 17949504. doi:10.1186/1745-0179-3-21
Hart H, Radua J, Nakao T, Mataix-Cols D, Rubia K (fevereiro de 2013). «Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects». JAMA Psychiatry. 70 (2): 185–198. PMID 23247506. doi:10.1001/jamapsychiatry.2013.277
Spencer TJ, Brown A, Seidman LJ, Valera EM, Makris N, Lomedico A, Faraone SV, Biederman J (setembro de 2013). «Effect of psychostimulants on brain structure and function in ADHD: a qualitative literature review of magnetic resonance imaging-based neuroimaging studies». J. Clin. Psychiatry. 74 (9): 902–917. PMC 3801446. PMID 24107764. doi:10.4088/JCP.12r08287
Frodl T, Skokauskas N (fevereiro de 2012). «Meta-analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects.». Acta Psychiatrica Scandinavica (Meta-analysis). 125 (2): 114–126. PMID 22118249. doi:10.1111/j.1600-0447.2011.01786.x. As regiões dos gânglios basais, como o globo pálido direito, o putâmen direito e o núcleo caudado, são estruturalmente afetadas em crianças com TDAH. Essas mudanças e alterações nas regiões límbicas, como o ACC e a amígdala, são mais pronunciadas em populações não tratadas e parecem diminuir com o tempo, da criança à idade adulta. O tratamento parece ter efeitos positivos na estrutura cerebral.
Nissen SE (abril de 2006). «ADHD drugs and cardiovascular risk». N. Engl. J. Med. 354 (14): 1445–1448. PMID 16549404. doi:10.1056/NEJMp068049
Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC, Murray KT, Quinn VP, Stein CM, Callahan ST, Fireman BH, Fish FA, Kirshner HS, O'Duffy A, Connell FA, Ray WA (novembro de 2011). «ADHD drugs and serious cardiovascular events in children and young adults». N. Engl. J. Med. 365 (20): 1896–1904. PMC 4943074. PMID 22043968. doi:10.1056/NEJMoa1110212
Habel LA, Cooper WO, Sox CM, Chan KA, Fireman BH, Arbogast PG, Cheetham TC, Quinn VP, Dublin S, Boudreau DM, Andrade SE, Pawloski PA, Raebel MA, Smith DH, Achacoso N, Uratsu C, Go AS, Sidney S, Nguyen-Huynh MN, Ray WA, Selby JV (dezembro de 2011). «ADHD medications and risk of serious cardiovascular events in young and middle-aged adults». JAMA. 306 (24): 2673–2683. PMC 3350308. PMID 22161946. doi:10.1001/jama.2011.1830
Steiner H, Van Waes V (janeiro de 2013). «Addiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulants». Prog. Neurobiol. 100: 60–80. PMC 3525776. PMID 23085425. doi:10.1016/j.pneurobio.2012.10.001
Kimko HC, Cross JT, Abernethy DR (dezembro de 1999). «Pharmacokinetics and clinical effectiveness of methylphenidate». Clin Pharmacokinet. 37 (6): 457–470. PMID 10628897. doi:10.2165/00003088-199937060-00002
Vitiello B (outubro de 2001). «Psychopharmacology for young children: clinical needs and research opportunities». Pediatrics. 108 (4): 983–989. PMID 11581454. doi:10.1542/peds.108.4.983
Huang YS, Tsai MH (julho de 2011). «Long-term outcomes with medications for attention-deficit hyperactivity disorder: current status of knowledge». CNS Drugs. 25 (7): 539–554. PMID 21699268. doi:10.2165/11589380-000000000-00000. Estudos recentes demonstraram que os estimulantes, juntamente com os não estimulantes atomoxetina e guanfacina de liberação prolongada, são continuamente eficazes por períodos de tratamento de mais de dois anos, com poucos e toleráveis efeitos adversos.
Vitiello B (abril de 2008). «Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function». Child Adolesc. Psychiatr. Clin. N. Am. 17 (2): 459–474. PMC 2408826. PMID 18295156. doi:10.1016/j.chc.2007.11.010
Chavez B, Sopko MA, Ehret MJ, Paulino RE, Goldberg KR, Angstadt K, Bogart GT (junho de 2009). «An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder». Ann. Pharmacother. 43 (6): 1084–1095. PMID 19470858. doi:10.1345/aph.1L523
Molina BS, Hinshaw SP, Swanson JM, et al. (março de 2009). «The MTA at 8 Years: Prospective Follow-Up of Children Treated for Combined Type ADHD in a Multisite Study». J Am Acad Child Adolesc Psychiatry. 48 (5): 484–500. PMC 3063150. PMID 19318991. doi:10.1097/CHI.0b013e31819c23d0
King S, Griffin S, Hodges Z, et al. (junho de 2006). «A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents». Health Technol Assess. 10 (23): iii–iv, xiii–146. PMID 16796929. doi:10.3310/hta10230. Cópia arquivada em 15 de agosto de 2009
Brown RT, Amler RW, Freeman WS, et al. (junho de 2005). «Treatment of attention-deficit/hyperactivity disorder: overview of the evidence». Pediatrics. 115 (6): e749–e757. PMID 15930203. doi:10.1542/peds.2004-2560
Frank, Elliot; Ozon, Cristina; Nair, Vinitha; Othee, Karandeep (25 de novembro de 2015). «Examining Why Patients With Attention-Deficit/Hyperactivity Disorder Lack Adherence to Medication Over the Long-Term». The Journal of Clinical Psychiatry (Review). 76 (11): e1459–e1468. ISSN 0160-6689. PMID 26646041. doi:10.4088/jcp.14r09478
Power, Thomas J.; Russell, Heather F.; Soffer, Stephen L.; Blom-Hoffman, Jessica; Grim, Suzanne M. (2002). «Role of Parent Training in the Effective Management of Attention-Deficit/Hyperactivity Disorder». Disease Management and Health Outcomes (Review). 10 (2): 117–126. ISSN 1173-8790. doi:10.2165/00115677-200210020-00007
Jim Rosack (2001). «Controversy Erupts Over Ads for ADHD Drugs». Psychiatric News. 36 (21): 20–21. doi:10.1176/pn.36.21.0020. Cópia arquivada em 2 de setembro de 2003
Kollins SH, MacDonald EK, Rush CR (março de 2001). «Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review». Pharmacol. Biochem. Behav. 68 (3): 611–627. PMID 11325419. doi:10.1016/S0091-3057(01)00464-6
Wilens TE, Adler LA, Adams J, et al. (janeiro de 2008). «Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature». J Am Acad Child Adolesc Psychiatry. 47 (1): 21–31. PMID 18174822. doi:10.1097/chi.0b013e31815a56f1
McCabe SE, Knight JR, Teter CJ, Wechsler H (janeiro de 2005). «Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey» (PDF). Addiction. 100 (1): 96–106. PMID 15598197. doi:10.1111/j.1360-0443.2005.00944.x. hdl:2027.42/74786
Santosh PJ, Taylor E (2000). «Stimulant drugs». European Child & Adolescent Psychiatry (Review). 9 (Suppl 1): I27–I43. PMID 11140778. doi:10.1007/s007870070017
Goldman LS, Genel M, Bezman RJ, Slanetz PJ (abril de 1998). «Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association». JAMA. 279 (14): 1100–1107. PMID 9546570. doi:10.1001/jama.279.14.1100

fda.gov

«FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults». United States Food and Drug Administration. 20 de dezembro de 2011. Consultado em 4 de novembro de 2013
«FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults». United States Food and Drug Administration. 15 de dezembro de 2011. Consultado em 4 de novembro de 2013
«Focalin XR (dexmethylphenidate hydrochloride) extended-release capsules CII». Warning Letters. U.S. Food and Drug Administration. 25 de setembro de 2008. Consultado em 5 de agosto de 2009
«CONCERTA (methylphenidate HCI) Extended-release Tablets CII». Warning Letters. U.S. Food and Drug Administration. 25 de setembro de 2008. Consultado em 5 de agosto de 2009
«Adderall XR Capsules». Warning Letters. US Food and Drug Administration. 25 de setembro de 2008. Consultado em 5 de agosto de 2009

handle.net

hdl.handle.net

McCabe SE, Knight JR, Teter CJ, Wechsler H (janeiro de 2005). «Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey» (PDF). Addiction. 100 (1): 96–106. PMID 15598197. doi:10.1111/j.1360-0443.2005.00944.x. hdl:2027.42/74786

hta.ac.uk

King S, Griffin S, Hodges Z, et al. (junho de 2006). «A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents». Health Technol Assess. 10 (23): iii–iv, xiii–146. PMID 16796929. doi:10.3310/hta10230. Cópia arquivada em 15 de agosto de 2009

independent.co.uk

Adams G. (9 de julho de 2008). «Harvard medics 'concealed drug firm cash'». London. The Independent. Consultado em 25 de abril de 2010. Cópia arquivada em 9 de junho de 2008

latimes.com

Sappell, Joel; Welkos, Robert W. (29 de junho de 1990). «Suits, Protests Fuel a Campaign Against Psychiatry». Los Angeles Times. p. A48:1. Consultado em 29 de novembro de 2006. Cópia arquivada em 4 de março de 2008

nice.org.uk

«CG72 Attention deficit hyperactivity disorder (ADHD): full guideline» (PDF). UK: National Health Service. 24 de setembro de 2008. Consultado em 8 de outubro de 2008
«Attention deficit hyperactivity disorder2013». NICE
«Attention deficit hyperactivity disorder (update)». NICE

nih.gov

ncbi.nlm.nih.gov

Faraone SV, et al. (2021). «The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder». Elsevier BV. Neuroscience & Biobehavioral Reviews. 128: 789–818. ISSN 0149-7634. PMC 8328933. PMID 33549739. doi:10.1016/j.neubiorev.2021.01.022
Elder TE (setembro de 2010). «The importance of relative standards in ADHD diagnoses: evidence based on exact birth dates». Journal of Health Economics. 29 (5): 641–656. PMC 2933294. PMID 20638739. doi:10.1016/j.jhealeco.2010.06.003
Merten EC, Cwik JC, Margraf J, Schneider S (2017). «Overdiagnosis of mental disorders in children and adolescents (in developed countries)». Child and Adolescent Psychiatry and Mental Health. 11. 5 páginas. PMC 5240230. PMID 28105068. doi:10.1186/s13034-016-0140-5
Taylor E (abril de 2017). «Attention deficit hyperactivity disorder: overdiagnosed or diagnoses missed?». Archives of Disease in Childhood. 102 (4): 376–379. PMID 27821518. doi:10.1136/archdischild-2016-310487
Sim MG, Hulse G, Khong E (agosto de 2004). «When the child with ADHD grows up». Australian Family Physician (Review). 33 (8): 615–8. PMID 15373378
Mayes R, Bagwell C, Erkulwater J (2008). «ADHD and the rise in stimulant use among children». Harvard Review of Psychiatry (Review). 16 (3): 151–66. PMID 18569037. doi:10.1080/10673220802167782
Ford T, Goodman R, Meltzer H (outubro de 2003). «The British Child and Adolescent Mental Health Survey 1999: the prevalence of DSM-IV disorders». Journal of the American Academy of Child and Adolescent Psychiatry. 42 (10): 1203–1211. PMID 14560170. doi:10.1097/00004583-200310000-00011
Polanczyk, G.; De Lima, M. S.; Horta, B. L.; Biederman, J.; Rohde, L. A. (2007). «The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis». American Journal of Psychiatry (Meta-analysis). 164 (6): 942–948. PMID 17541055. doi:10.1176/appi.ajp.164.6.942
Cortese S, Castellanos FX (outubro de 2012). «Neuroimaging of attention-deficit/hyperactivity disorder: current neuroscience-informed perspectives for clinicians». Curr Psychiatry Rep (Review). 14 (5): 568–578. PMC 3876939. PMID 22851201. doi:10.1007/s11920-012-0310-y
Shaw, Philip; Lerch, Jason; Greenstein, Deanna; Sharp, Wendy; Clasen, Liv; Evans, Alan; Giedd, Jay; Castellanos, F. Xavier; Rapoport, Judith (2006). «Longitudinal Mapping of Cortical Thickness and Clinical Outcome in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder». Arch Gen Psychiatry. 63 (5): 540–549. PMID 16651511. doi:10.1001/archpsyc.63.5.540
Nikolas, Molly A.; Burt, S. Alexandra (1 de fevereiro de 2010). «Genetic and environmental influences on ADHD symptom dimensions of inattention and hyperactivity: a meta-analysis». Journal of Abnormal Psychology (Meta-analysis). 119 (1): 1–17. ISSN 1939-1846. PMID 20141238. doi:10.1037/a0018010
M. T. Acosta; M. Arcos-Burgos; M. Muenke (2004). «Attention deficit/hyperactivity disorder (ADHD): Complex phenotype, simple genotype?». Genetics in Medicine (Review). 6 (1): 1–15. PMID 14726804. doi:10.1097/01.GIM.0000110413.07490.0B
Parens E, Johnston J (2009). «Facts, values, and Attention-Deficit Hyperactivity Disorder (ADHD): an update on the controversies». Child and Adolescent Psychiatry and Mental Health (Workshops). 3 (1). 1 páginas. PMC 2637252. PMID 19152690. doi:10.1186/1753-2000-3-1
Singh I (dezembro de 2008). «Beyond polemics: science and ethics of ADHD». Nature Reviews Neuroscience (Review). 9 (12): 957–964. PMID 19020513. doi:10.1038/nrn2514
Timimi, Sami; Taylor, Eric (janeiro de 2004). «In Debate: ADHD is best understood as a cultural construct». British Journal of Psychiatry. 184 (1): 8–9. PMID 14702221. doi:10.1192/bjp.184.1.8
Benning, Tony B. (dezembro de 2016). «No such thing as mental illness? Critical reflections on the major ideas and legacy of Thomas Szasz». BJPsych Bulletin (em inglês). 40 (6): 292–295. ISSN 2056-4694. PMC 5353517. PMID 28377805. doi:10.1192/pb.bp.115.053249
Taylor E.; Chadwick O.; Heptinstall E.; et al. (1996). «Hyperactivity and conduct problems as risk factors for adolescent development». Journal of the American Academy of Child and Adolescent Psychiatry. 35 (9): 1213–1226. PMID 8824065. doi:10.1097/00004583-199609000-00019
Meltzer, H.; Gatward, R.; Goodman, R.; Ford, T. (2003). «Mental health of children and adolescents in Great Britain». Informa UK Limited. International Review of Psychiatry. 15 (1–2): 185–187. ISSN 0954-0261. PMID 12745331. doi:10.1080/0954026021000046155
Mahone, E. M.; Wodka, E. L. (2008). «The neurobiological profile of girls with ADHD». Developmental Disabilities Research Reviews. 14 (4): 276–284. PMC 3534724. PMID 19072756. doi:10.1002/ddrr.41 Verifique o valor de |name-list-format=amp (ajuda)
Sciutto M. J., Eisenberg M. (2007). «Evaluating the Evidence For and Against the Overdiagnosis of ADHD». Journal of Attention Disorders. 11 (2): 106–113. PMID 17709814. doi:10.1177/1087054707300094
Cuffe, SP; Moore, CG; McKeown, RE (2005). «Prevalence and correlates of ADHD symptoms in the National Health Interview Survey». Journal of Attention Disorders. 9 (2): 392–401. PMID 16371662. doi:10.1177/1087054705280413
Morely, CP (2010). «Disparities in ADHD assessment, diagnosis and treatment». International Journal of Psychiatry in Medicine. 40 (4): 383–389. PMID 21391409. doi:10.2190/PM.40.4.b
Harrison, JR; Vannest, KJ; Reynolds, CR (2011). «Behaviors that discriminate ADHD in children and adolescents: Primary symptoms, symptoms of comorbid conditions or indicators of functional impairment?». Journal of Attention Disorders. 15 (2): 147–160. PMID 20354233. doi:10.1177/1087054709356170
Morrow, R; Garland, J; Wright, J; Maclure, M; et al. (17 de abril de 2012). «Influence of relative age on diagnosis and treatment of Attention-Deficit/Hyperactivity Disorder in children». Canadian Medical Association Journal. 184 (7): 755–762. PMC 3328520. PMID 22392937. doi:10.1503/cmaj.111619
Able, SL; Johnston, JA; Adler, LA; Swindle, RW (2007). «Functional and psychosocial impairment in adults with undiagnosed ADHD». Psychological Medicine. 37 (1): 97–107. PMID 16938146. doi:10.1017/s0033291706008713
Kessler, RC; Adler, L; Barley, R; Biederman, J; et al. (2006). «The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication». The American Journal of Psychiatry. 163 (4): 716–723. PMC 2859678. PMID 16585449. doi:10.1176/appi.ajp.163.4.716
Bruchmuller, K; Margraf, J; Schneider, S (2012). «Is ADHD diagnosed in accord with diagnostic criteria? Overdiagnosis and influence of client gender on diagnosis». Journal of Consulting and Clinical Psychology. 80 (1): 128–138. PMID 22201328. doi:10.1037/a0026582
Beiderman, J., Joseph; Stephen Farone; Eric Mick (1999). «Clinical correlates of ADHD in females: Findings from a large group of girls ascertained from pediatric and psychiatric referral sources». Journal of the American Academy of Child and Adolescent Psychiatry. 38 (8): 966–975. PMID 10434488. doi:10.1097/00004583-199908000-00012
Norvilitis JM, Fang P (novembro de 2005). «Perceptions of ADHD in China and the United States: a preliminary study». J Atten Disord. 9 (2): 413–424. PMID 16371664. doi:10.1177/1087054705281123
Reason R; Working Party of the British Psychological Society (1999). «ADHD: a psychological response to an evolving concept. (Report of a Working Party of the British Psychological Society)». Journal of Learning Disabilities. 32 (1): 85–91. PMID 15499890. doi:10.1177/002221949903200108
Ford-Jones, Polly Christine (maio de 2015). «Misdiagnosis of attention deficit hyperactivity disorder: 'Normal behaviour' and relative maturity». Paediatrics & Child Health. 20 (4): 200–202. ISSN 1205-7088. PMC 4443828. PMID 26038639. doi:10.1093/pch/20.4.200
McDonagh, Marian S.; Peterson, Kim; Dana, Tracy; Thakurta, Sujata (2007). Drug Class Review on Pharmacologic Treatments for ADHD: Final Report. Col: Drug Class Reviews. Portland (OR): Oregon Health & Science University. PMID 20480923
Marwick, C. (11 de janeiro de 2003). «US doctor warns of misuse of prescribed stimulants». Washington, DC. BMJ (news article). 326 (7380): 67. ISSN 0959-8138. PMC 1125021. PMID 12521954. doi:10.1136/bmj.326.7380.67
Jensen PS, Kettle L, Roper MT, et al. (julho de 1999). «Are stimulants overprescribed? Treatment of ADHD in four U.S. communities». Journal of the American Academy of Child and Adolescent Psychiatry. 38 (7): 797–804. PMID 10405496. doi:10.1097/00004583-199907000-00008
Lakhan SE, Hagger-Johnson GE (2007). «The impact of prescribed psychotropics on youth». Clin Pract Epidemiol Ment Health. 3 (1). 21 páginas. PMC 2100041. PMID 17949504. doi:10.1186/1745-0179-3-21
Hart H, Radua J, Nakao T, Mataix-Cols D, Rubia K (fevereiro de 2013). «Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects». JAMA Psychiatry. 70 (2): 185–198. PMID 23247506. doi:10.1001/jamapsychiatry.2013.277
Spencer TJ, Brown A, Seidman LJ, Valera EM, Makris N, Lomedico A, Faraone SV, Biederman J (setembro de 2013). «Effect of psychostimulants on brain structure and function in ADHD: a qualitative literature review of magnetic resonance imaging-based neuroimaging studies». J. Clin. Psychiatry. 74 (9): 902–917. PMC 3801446. PMID 24107764. doi:10.4088/JCP.12r08287
Frodl T, Skokauskas N (fevereiro de 2012). «Meta-analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects.». Acta Psychiatrica Scandinavica (Meta-analysis). 125 (2): 114–126. PMID 22118249. doi:10.1111/j.1600-0447.2011.01786.x. As regiões dos gânglios basais, como o globo pálido direito, o putâmen direito e o núcleo caudado, são estruturalmente afetadas em crianças com TDAH. Essas mudanças e alterações nas regiões límbicas, como o ACC e a amígdala, são mais pronunciadas em populações não tratadas e parecem diminuir com o tempo, da criança à idade adulta. O tratamento parece ter efeitos positivos na estrutura cerebral.
Nissen SE (abril de 2006). «ADHD drugs and cardiovascular risk». N. Engl. J. Med. 354 (14): 1445–1448. PMID 16549404. doi:10.1056/NEJMp068049
Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC, Murray KT, Quinn VP, Stein CM, Callahan ST, Fireman BH, Fish FA, Kirshner HS, O'Duffy A, Connell FA, Ray WA (novembro de 2011). «ADHD drugs and serious cardiovascular events in children and young adults». N. Engl. J. Med. 365 (20): 1896–1904. PMC 4943074. PMID 22043968. doi:10.1056/NEJMoa1110212
Habel LA, Cooper WO, Sox CM, Chan KA, Fireman BH, Arbogast PG, Cheetham TC, Quinn VP, Dublin S, Boudreau DM, Andrade SE, Pawloski PA, Raebel MA, Smith DH, Achacoso N, Uratsu C, Go AS, Sidney S, Nguyen-Huynh MN, Ray WA, Selby JV (dezembro de 2011). «ADHD medications and risk of serious cardiovascular events in young and middle-aged adults». JAMA. 306 (24): 2673–2683. PMC 3350308. PMID 22161946. doi:10.1001/jama.2011.1830
Steiner H, Van Waes V (janeiro de 2013). «Addiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulants». Prog. Neurobiol. 100: 60–80. PMC 3525776. PMID 23085425. doi:10.1016/j.pneurobio.2012.10.001
Kimko HC, Cross JT, Abernethy DR (dezembro de 1999). «Pharmacokinetics and clinical effectiveness of methylphenidate». Clin Pharmacokinet. 37 (6): 457–470. PMID 10628897. doi:10.2165/00003088-199937060-00002
Vitiello B (outubro de 2001). «Psychopharmacology for young children: clinical needs and research opportunities». Pediatrics. 108 (4): 983–989. PMID 11581454. doi:10.1542/peds.108.4.983
Huang YS, Tsai MH (julho de 2011). «Long-term outcomes with medications for attention-deficit hyperactivity disorder: current status of knowledge». CNS Drugs. 25 (7): 539–554. PMID 21699268. doi:10.2165/11589380-000000000-00000. Estudos recentes demonstraram que os estimulantes, juntamente com os não estimulantes atomoxetina e guanfacina de liberação prolongada, são continuamente eficazes por períodos de tratamento de mais de dois anos, com poucos e toleráveis efeitos adversos.
Vitiello B (abril de 2008). «Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function». Child Adolesc. Psychiatr. Clin. N. Am. 17 (2): 459–474. PMC 2408826. PMID 18295156. doi:10.1016/j.chc.2007.11.010
Chavez B, Sopko MA, Ehret MJ, Paulino RE, Goldberg KR, Angstadt K, Bogart GT (junho de 2009). «An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder». Ann. Pharmacother. 43 (6): 1084–1095. PMID 19470858. doi:10.1345/aph.1L523
Molina BS, Hinshaw SP, Swanson JM, et al. (março de 2009). «The MTA at 8 Years: Prospective Follow-Up of Children Treated for Combined Type ADHD in a Multisite Study». J Am Acad Child Adolesc Psychiatry. 48 (5): 484–500. PMC 3063150. PMID 19318991. doi:10.1097/CHI.0b013e31819c23d0
King S, Griffin S, Hodges Z, et al. (junho de 2006). «A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents». Health Technol Assess. 10 (23): iii–iv, xiii–146. PMID 16796929. doi:10.3310/hta10230. Cópia arquivada em 15 de agosto de 2009
Brown RT, Amler RW, Freeman WS, et al. (junho de 2005). «Treatment of attention-deficit/hyperactivity disorder: overview of the evidence». Pediatrics. 115 (6): e749–e757. PMID 15930203. doi:10.1542/peds.2004-2560
Frank, Elliot; Ozon, Cristina; Nair, Vinitha; Othee, Karandeep (25 de novembro de 2015). «Examining Why Patients With Attention-Deficit/Hyperactivity Disorder Lack Adherence to Medication Over the Long-Term». The Journal of Clinical Psychiatry (Review). 76 (11): e1459–e1468. ISSN 0160-6689. PMID 26646041. doi:10.4088/jcp.14r09478
Kollins SH, MacDonald EK, Rush CR (março de 2001). «Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review». Pharmacol. Biochem. Behav. 68 (3): 611–627. PMID 11325419. doi:10.1016/S0091-3057(01)00464-6
Wilens TE, Adler LA, Adams J, et al. (janeiro de 2008). «Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature». J Am Acad Child Adolesc Psychiatry. 47 (1): 21–31. PMID 18174822. doi:10.1097/chi.0b013e31815a56f1
McCabe SE, Knight JR, Teter CJ, Wechsler H (janeiro de 2005). «Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey» (PDF). Addiction. 100 (1): 96–106. PMID 15598197. doi:10.1111/j.1360-0443.2005.00944.x. hdl:2027.42/74786
Santosh PJ, Taylor E (2000). «Stimulant drugs». European Child & Adolescent Psychiatry (Review). 9 (Suppl 1): I27–I43. PMID 11140778. doi:10.1007/s007870070017
«Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder (ADHD)» (PDF). National Institutes of Health. NIH Consens Statement. 16 (2): 1–37. Nov 16–18, 1998. PMID 10868163
Goldman LS, Genel M, Bezman RJ, Slanetz PJ (abril de 1998). «Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association». JAMA. 279 (14): 1100–1107. PMID 9546570. doi:10.1001/jama.279.14.1100

nimh.nih.gov

«Attention Deficit Hyperactivity Disorder». National Institute of Mental Health. Consultado em 5 de março de 2016
«NIMH · ADHD · The Treatment of ADHD»
«Global Use of ADHD Medications Rises Dramatically». NIMH. 6 de março de 2007. Consultado em 6 de maio de 2013. Cópia arquivada em 12 de maio de 2013

consensus.nih.gov

«Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder (ADHD)» (PDF). National Institutes of Health. NIH Consens Statement. 16 (2): 1–37. Nov 16–18, 1998. PMID 10868163

nrk.no

Bergløff, Charlotte Berrefjord; Tor Risberg; Kjell Herning (2 de maio de 2005). «Mister diagnosen AD/HD» [[They] Lose the Diagnosis ADHD] (em norueguês). Norwegian National Broadcasting. Consultado em 9 de maio de 2009. Cópia arquivada em 27 de outubro de 2009

nybooks.com

«Marcia Angell». The New York Review of Books. Consultado em 21 de julho de 2009. Marcia Angell is a Senior Lecturer in Social Medicine at Harvard Medical School. A physician, she is a former Editor in Chief of The New England Journal of Medicine.
Angell, Marcia (15 de janeiro de 2009). «Drug Companies & Doctors: A Story of Corruption». The New York Review of Books. Consultado em 21 de julho de 2009

nytimes.com

Harris, Gardiner; Carey, Benedict (8 de junho de 2008). «Researchers Fail to Reveal Full Drug Pay». The New York Times. Consultado em 25 de abril de 2010

pbs.org

«Statistics on Stimulant Use». Public Broadcasting Service. Consultado em 31 de março de 2013
«Interview: Russell Barkley». Frontline. Medicating kids. PBS. 10 de abril de 2001. Cópia arquivada em 31 de julho de 2016
«Interview: Harvey Parker». Frontline. Medicating kids. PBS. 12 de setembro de 2000. Cópia arquivada em 11 de março de 2016

pharmalot.com

«FDA Warns Five Drugmakers Over ADHD Ads». Pharmalot. UBM Canon Pharmaceutical Media Group. Cópia arquivada em 8 de setembro de 2012

psychiatryonline.com

«Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision: Attention-Deficit/Hyperactivity Disorder». PsychiatryOnline. Consultado em 9 de agosto de 2009. Cópia arquivada em 25 de agosto de 2009

psychiatryonline.org

pn.psychiatryonline.org

Jim Rosack (2001). «Controversy Erupts Over Ads for ADHD Drugs». Psychiatric News. 36 (21): 20–21. doi:10.1176/pn.36.21.0020. Cópia arquivada em 2 de setembro de 2003

psychrights.org

David Cohen; Jonathan Leo (2004). «An Update on ADHD Neuroimaging Research» (PDF). The Institute of Mind and Behavior, Inc. The Journal of Mind and Behavior. 25 (2): 161–166. ISSN 0271-0137

rcpsych.org

bjp.rcpsych.org

Timimi, Sami; Taylor, Eric (janeiro de 2004). «In Debate: ADHD is best understood as a cultural construct». British Journal of Psychiatry. 184 (1): 8–9. PMID 14702221. doi:10.1192/bjp.184.1.8

reuters.com

«With ADHD, amphetamine has double the psychosis risk of methylphenidate». Reuters. 20 de março de 2019

slate.com

Saletan, William (12 de janeiro de 2009). «Doping Deficit Disorder: Need performance-enhancing drugs? Claim ADHD». Slate. The Slate Group LLC. Consultado em 2 de maio de 2009. Cópia arquivada em 21 de maio de 2009

telegraph.co.uk

Singh, Anita (25 de fevereiro de 2010). «BBC must broadcast apology over inaccurate Panorama programme». The Telegraph. Consultado em 29 de janeiro de 2012

timesonline.co.uk

Kealey, Terence (4 de junho de 2004). «Boisterous boys are too much like hard work so we drug them into conformity». The Times. London. Consultado em 25 de abril de 2010

ubc.ca

ti.ubc.ca

«What is the evidence for using CNS stimulants to treat ADHD in children?». Março de 2008. Consultado em 20 de março de 2011

umich.edu

deepblue.lib.umich.edu

McCabe SE, Knight JR, Teter CJ, Wechsler H (janeiro de 2005). «Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey» (PDF). Addiction. 100 (1): 96–106. PMID 15598197. doi:10.1111/j.1360-0443.2005.00944.x. hdl:2027.42/74786

unodc.org

Chawla S, Le Pichon T (2006). «World Drug Report 2006» (PDF). United Nations Office on Drugs and Crime. pp. 143–144. Consultado em 2 de novembro de 2013

uptodate.com

Krull KR (29 de outubro de 2021). «Attention Deficit Hyperactivity Disorder in Children and Adolescents: Epidemiology and Pathogenesis». In: Augustyn M, Torchia MM. UpToDate. Consultado em 7 de maio de 2022

web.archive.org

«Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision: Attention-Deficit/Hyperactivity Disorder». PsychiatryOnline. Consultado em 9 de agosto de 2009. Cópia arquivada em 25 de agosto de 2009
«Attention-deficit/hyperactivity disorder: Controversy – mental disorder or state of mind?». Encyclopædia Britannica (em inglês). Cópia arquivada em 15 de maio de 2010
«Global Use of ADHD Medications Rises Dramatically». NIMH. 6 de março de 2007. Consultado em 6 de maio de 2013. Cópia arquivada em 12 de maio de 2013
King S, Griffin S, Hodges Z, et al. (junho de 2006). «A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents». Health Technol Assess. 10 (23): iii–iv, xiii–146. PMID 16796929. doi:10.3310/hta10230. Cópia arquivada em 15 de agosto de 2009
Jim Rosack (2001). «Controversy Erupts Over Ads for ADHD Drugs». Psychiatric News. 36 (21): 20–21. doi:10.1176/pn.36.21.0020. Cópia arquivada em 2 de setembro de 2003
Saletan, William (12 de janeiro de 2009). «Doping Deficit Disorder: Need performance-enhancing drugs? Claim ADHD». Slate. The Slate Group LLC. Consultado em 2 de maio de 2009. Cópia arquivada em 21 de maio de 2009
Sappell, Joel; Welkos, Robert W. (29 de junho de 1990). «Suits, Protests Fuel a Campaign Against Psychiatry». Los Angeles Times. p. A48:1. Consultado em 29 de novembro de 2006. Cópia arquivada em 4 de março de 2008
Adams G. (9 de julho de 2008). «Harvard medics 'concealed drug firm cash'». London. The Independent. Consultado em 25 de abril de 2010. Cópia arquivada em 9 de junho de 2008
«Interview: Russell Barkley». Frontline. Medicating kids. PBS. 10 de abril de 2001. Cópia arquivada em 31 de julho de 2016
«Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder» (PDF). American Academy of Child & Adolescent Psychiatry. Consultado em 9 de outubro de 2008. Cópia arquivada (PDF) em 17 de dezembro de 2008
«Interview: Harvey Parker». Frontline. Medicating kids. PBS. 12 de setembro de 2000. Cópia arquivada em 11 de março de 2016
Bergløff, Charlotte Berrefjord; Tor Risberg; Kjell Herning (2 de maio de 2005). «Mister diagnosen AD/HD» [[They] Lose the Diagnosis ADHD] (em norueguês). Norwegian National Broadcasting. Consultado em 9 de maio de 2009. Cópia arquivada em 27 de outubro de 2009

webmd.com

«Diagnosing ADHD in Children and Adults». WebMD (em inglês). Consultado em 4 de janeiro de 2021
«Stimulants for Attention Deficit Hyperactivity Disorder». WebMD. Healthwise. 12 de abril de 2010. Consultado em 12 de novembro de 2013
Zwillich, Todd (16 de novembro de 2005). «Schools Can't Require ADHD Drugs». WebMD

worldcat.org

Faraone SV, et al. (2021). «The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder». Elsevier BV. Neuroscience & Biobehavioral Reviews. 128: 789–818. ISSN 0149-7634. PMC 8328933. PMID 33549739. doi:10.1016/j.neubiorev.2021.01.022
David Cohen; Jonathan Leo (2004). «An Update on ADHD Neuroimaging Research» (PDF). The Institute of Mind and Behavior, Inc. The Journal of Mind and Behavior. 25 (2): 161–166. ISSN 0271-0137
Nikolas, Molly A.; Burt, S. Alexandra (1 de fevereiro de 2010). «Genetic and environmental influences on ADHD symptom dimensions of inattention and hyperactivity: a meta-analysis». Journal of Abnormal Psychology (Meta-analysis). 119 (1): 1–17. ISSN 1939-1846. PMID 20141238. doi:10.1037/a0018010
Glenmullen, J. (2000). Prozac Backlash: Overcoming the Dangers of Prozac, Zoloft, Paxil, and Other Antidepressants with Safe, Effective Alternatives. New York: Simon & Schuster. pp. 192–198. ISBN 978-0-7432-0062-2. OCLC 42968080
Barkley, Russell A. (2004). 20 Coendorsers. «Critique or Misrepresentation? A Reply to Timimi et al.». Springer Science and Business Media LLC. Clinical Child and Family Psychology Review. 7 (1): 65–69. ISSN 1096-4037. doi:10.1023/b:ccfp.0000020193.48817.30
Benning, Tony B. (dezembro de 2016). «No such thing as mental illness? Critical reflections on the major ideas and legacy of Thomas Szasz». BJPsych Bulletin (em inglês). 40 (6): 292–295. ISSN 2056-4694. PMC 5353517. PMID 28377805. doi:10.1192/pb.bp.115.053249
Meltzer, H.; Gatward, R.; Goodman, R.; Ford, T. (2003). «Mental health of children and adolescents in Great Britain». Informa UK Limited. International Review of Psychiatry. 15 (1–2): 185–187. ISSN 0954-0261. PMID 12745331. doi:10.1080/0954026021000046155
Ford-Jones, Polly Christine (maio de 2015). «Misdiagnosis of attention deficit hyperactivity disorder: 'Normal behaviour' and relative maturity». Paediatrics & Child Health. 20 (4): 200–202. ISSN 1205-7088. PMC 4443828. PMID 26038639. doi:10.1093/pch/20.4.200
Marwick, C. (11 de janeiro de 2003). «US doctor warns of misuse of prescribed stimulants». Washington, DC. BMJ (news article). 326 (7380): 67. ISSN 0959-8138. PMC 1125021. PMID 12521954. doi:10.1136/bmj.326.7380.67
Frank, Elliot; Ozon, Cristina; Nair, Vinitha; Othee, Karandeep (25 de novembro de 2015). «Examining Why Patients With Attention-Deficit/Hyperactivity Disorder Lack Adherence to Medication Over the Long-Term». The Journal of Clinical Psychiatry (Review). 76 (11): e1459–e1468. ISSN 0160-6689. PMID 26646041. doi:10.4088/jcp.14r09478
Power, Thomas J.; Russell, Heather F.; Soffer, Stephen L.; Blom-Hoffman, Jessica; Grim, Suzanne M. (2002). «Role of Parent Training in the Effective Management of Attention-Deficit/Hyperactivity Disorder». Disease Management and Health Outcomes (Review). 10 (2): 117–126. ISSN 1173-8790. doi:10.2165/00115677-200210020-00007

zenodo.org

Jensen PS, Kettle L, Roper MT, et al. (julho de 1999). «Are stimulants overprescribed? Treatment of ADHD in four U.S. communities». Journal of the American Academy of Child and Adolescent Psychiatry. 38 (7): 797–804. PMID 10405496. doi:10.1097/00004583-199907000-00008